ABCG2 in peptic ulcer: gene expression and mutation analysis

[1]  A. Cressman,et al.  Maternal bacterial infections impact expression of drug transporters in human placenta. , 2015, International immunopharmacology.

[2]  M. Iwaki,et al.  Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats , 2015, European Journal of Drug Metabolism and Pharmacokinetics.

[3]  E. Balcerczak,et al.  ABCB1 expression in peptic ulcer patients and its connection with H. pylori Infection. , 2014, Annals of clinical and laboratory science.

[4]  Joshua Xu,et al.  ATP-Binding Cassette Genes Genotype and Expression: A Potential Association with Pancreatic Cancer Development and Chemoresistance? , 2014, Gastroenterology research and practice.

[5]  M. Guan,et al.  Functional Polymorphisms of the ABCG2 Gene Are Associated with Gout Disease in the Chinese Han Male Population , 2014, International journal of molecular sciences.

[6]  Z. Janka,et al.  Association between the ABCG2 C421A polymorphism and Alzheimer's disease , 2013, Neuroscience Letters.

[7]  Zhihao Liu,et al.  The transporters of intestinal tract and techniques applied to evaluate interactions between drugs and transporters , 2013 .

[8]  Yvonne S. Lin,et al.  Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype. , 2013, Journal of pharmaceutical sciences.

[9]  K. Søreide,et al.  Epidemiology of perforated peptic ulcer: age- and gender-adjusted analysis of incidence and mortality. , 2013, World journal of gastroenterology.

[10]  K. Leksowski,et al.  Stenosis pylori – a case report , 2012 .

[11]  K. Kim,et al.  ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations , 2010, Journal of clinical pharmacy and therapeutics.

[12]  S. Steinberg,et al.  Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival , 2008, BJU international.

[13]  Qingcheng Mao.  BCRP/ABCG2 in the Placenta: Expression, Function and Regulation , 2008, Pharmaceutical Research.

[14]  Jian-hua Chang,et al.  BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. , 2007, Carcinogenesis.

[15]  J. Keelan,et al.  Independent Regulation of Apical and Basolateral Drug Transporter Expression and Function in Placental Trophoblasts by Cytokines, Steroids, and Growth Factors , 2007, Drug Metabolism and Disposition.

[16]  M. Hidalgo,et al.  Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. , 2006, Journal of the National Cancer Institute.

[17]  C. Beglinger,et al.  Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. , 2005, Biochemical pharmacology.

[18]  Qingcheng Mao,et al.  Role of the breast cancer resistance protein (ABCG2) in drug transport , 2005, The AAPS Journal.

[19]  S. Bates,et al.  Single nucleotide polymorphisms modify the transporter activity of ABCG2 , 2005, Cancer Chemotherapy and Pharmacology.

[20]  J. Verweij,et al.  Effect of ABCG2 genotype on the oral vioavailability of topotecan , 2005, Cancer biology & therapy.

[21]  Y. Sugiyama,et al.  Functional Analysis of SNPs Variants of BCRP/ABCG2 , 2004, Pharmaceutical Research.

[22]  H. McLeod,et al.  ABCG2 Pharmacogenetics , 2004, Clinical Cancer Research.

[23]  H. Kotani,et al.  Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2 , 2004, International journal of cancer.

[24]  W. T. Beck,et al.  Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein (ABCG2) Gene , 2004, Cancer Research.

[25]  I. Catalá,et al.  Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material , 2002, The Journal of pathology.

[26]  P. Malfertheiner,et al.  Peptic ulcer disease , 2002, The Lancet.

[27]  Y. Miki,et al.  C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. , 2002, Molecular cancer therapeutics.

[28]  K. Kondo,et al.  Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8 , 2002, Journal of Human Genetics.

[29]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[30]  M. J. van de Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[31]  L. Doyle,et al.  A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Watkinson,et al.  Peptic ulcer disease , 1985, Digestive Diseases and Sciences.

[33]  Jian-Ting Zhang,et al.  Human ABCG2: structure, function, and its role in multidrug resistance. , 2012, International journal of biochemistry and molecular biology.

[34]  A. Tretyn,et al.  PCR in real time. The methods of data analysis , 2008 .

[35]  H. McLeod,et al.  ABCG2 Pharmacogenetics: Ethnic Differences in Allele Frequency and Assessment of Influence on Irinotecan Disposition , 2004 .

[36]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[37]  J. Schabowski.  Selected socio-economic features and the prevalence of peptic ulcer among Polish rural population. , 2002, Annals of agricultural and environmental medicine : AAEM.

[38]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .